UPDATE 1-Conatus Pharma's liver drug succeeds in mid-stage study, shares soar

March 26 (Reuters) - Conatus Pharmaceuticals Inc said its experimental lead drug was more effective than a placebo in a mid-stage study in patients with a form of fatty liver disease.

from Reuters: Hot Stocks http://ift.tt/1IywW7S